Because there was no significance between GGT-II and GPC3 in detecting all-stage HBV-HCC and HCV-HCC, we chose AFP, AFU, and HGF in a combination model (Figure 4F–4I). This evidence concerns the gene GPC3 and hepatocellular carcinoma.